Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
about
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.Dopamine receptors - IUPHAR Review 13Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesiaShp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease.Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease.Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression.The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's ratsIn silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's disease
P2860
Q27324174-0CFB77BB-EB5B-4BB1-A18A-9E181C7693F9Q28256783-9A3D7167-147D-4519-9C2E-9AE13B0F229FQ30833645-9AA024AC-CF1E-4747-9795-F02976CD309BQ34708186-D3739EF7-6447-4FBF-9125-780BF3A65837Q35777273-32EA8F56-40E8-473A-9433-A5AF2750A08DQ39981493-2B9ED8F4-971D-405E-A253-958DBF5CAFFDQ46794787-3F5392EF-4219-4818-9714-869EB38AF593Q49357267-2A4E14B3-3F4F-40BE-976B-817FE26F8A5CQ57177116-0610BBFF-2527-4357-8B5E-8CE3814E2426Q58716364-30779710-8226-455F-A6B9-C9AC9349427E
P2860
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
description
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2013
@ast
im Januar 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2013/06/01)
@sk
vědecký článek publikovaný v roce 2013
@cs
wetenschappelijk artikel (gepubliceerd op 2013/06/01)
@nl
наукова стаття, опублікована в червні 2013
@uk
مقالة علمية (نشرت في يونيو 2013)
@ar
name
Persistent activation of the D ...... t model of Parkinson's disease
@ast
Persistent activation of the D ...... t model of Parkinson's disease
@en
Persistent activation of the D ...... t model of Parkinson's disease
@nl
type
label
Persistent activation of the D ...... t model of Parkinson's disease
@ast
Persistent activation of the D ...... t model of Parkinson's disease
@en
Persistent activation of the D ...... t model of Parkinson's disease
@nl
prefLabel
Persistent activation of the D ...... t model of Parkinson's disease
@ast
Persistent activation of the D ...... t model of Parkinson's disease
@en
Persistent activation of the D ...... t model of Parkinson's disease
@nl
P2093
P921
P1476
Persistent activation of the D ...... t model of Parkinson's disease
@en
P2093
Chiara Fiorentini
Cristina Missale
Daria Savoldi
Paola Savoia
P304
P356
10.1016/J.NBD.2013.01.005
P577
2013-01-14T00:00:00Z